The Journal of Urology
Volume 182, Issue 3 , Pages 833-834 , September 2009

The Case for Cytoreductive Nephrectomy for the Management of Metastatic Renal Cell Carcinoma

References 

  1. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alpha-2b compared with interferon alpha-2b alone for metastatic renal cell cancer. N Engl J Med. 2001;345:1655
  2. Mickisch GH, Garin A, van Poppel H, et al. European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomized trial. Lancet. 2001;358:966
  3. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal cell carcinoma. N Engl J Med. 2007;356:115
  4. Motzer RJ, Rini BI, Bukowski RM, et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA. 2006;295:2516

PII: S0022-5347(09)01612-7

doi: 10.1016/j.juro.2009.06.077

The Journal of Urology
Volume 182, Issue 3 , Pages 833-834 , September 2009

Article Tools